Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{178497,
        author = {Sayyed Atik and Madaje Amir and Etesam Shaikh and Sayyad Azharali and Saudagar Sameer and Ansari Mohd Saquib},
        title = {Revolutionizing Drug Formulation: The Role of 3D Printing in Personalized Medicine},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {11},
        number = {12},
        pages = {5857-5864},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=178497},
        abstract = {3D printing (additive manufacturing) is revolutionizing pharmaceutical sciences by enabling the creation of customized drug formulations tailored to individual patient needs. Unlike traditional methods, it allows flexible dosage forms, complex geometries, and multi-drug combinations, improving patient compliance, especially in pediatric and geriatric populations. Techniques like FDM, SLA, and SLS offer unique benefits in drug delivery, while material selection and thermal stability remain crucial for product quality. Despite challenges in regulation and large-scale production, advancements in AI, smart materials, and decentralized models are paving the way for broader adoption. This review highlights the key technological, material, and regulatory aspects driving 3D printing’s role in personalized medicine.},
        keywords = {3D Printing, Additive Manufacturing, Personalized Medicine, Drug Formulation, Fused Deposition Modeling (FDM), Stereolithography (SLA), Selective Laser Sintering (SLS), Custom Dosage Forms, Polypill, Drug Release Profiles, Regulatory Challenges, Material Science, Thermal Stability of APIs},
        month = {May},
        }